Taiwan's Food and Drug Administration (FDA) on Saturday said it was reviewing the technical data on the Novavax COVID-19 vaccine following the American drugmaker's recent request for emergency use authorization (EUA) in Taiwan.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end at high ahead of TSMC investor conference
10/16/2025 04:59 PM - Business
U.S. dollar closes higher on Taipei forex market
10/16/2025 04:22 PM - Society
Taiwan recalls hypothyroidism drug over low active ingredient levels
10/16/2025 03:50 PM - Business
TSMC's Q3 net profit hits record as gross margin beats forecast
10/16/2025 03:49 PM - Culture
Ex-President Tsai rocks AI pink hair to mark upcoming Blackpink concert
10/16/2025 03:38 PM